Literature DB >> 30901274

Antitumor Effects of Ruyiping on Cell Growth and Metastasis in Breast Cancer.

Zhiyuan Li1, Xiaohui Sun2,3, Xiaoming Liu1, Ziyuan Sun2, Jingwei Li2.   

Abstract

Background: Ruyiping is an effective traditional Chinese herbal medicine formula for preventing postoperative recurrence and metastasis of breast cancer. However, the exact function and underlying mechanism of Ruyiping in breast cancer remain unclear. Materials and
Methods: After breast cancer cell lines MDA-MB-231 and MDA-MB-468 were treated with Ruyiping, the CCK8, colony formation, wound-healing, and transwell invasion assays were used to examine cell proliferation, migration, and invasion, respectively. Flow cytometry was performed to examine the effect of Ruyiping on cell cycle distribution. Western blot was performed to examine the expression of related proteins, and the activity of MMP9 was detected using Gelatin zymography assay.
Results: Ruyiping treatment significantly inhibited cell proliferation and viability of MDA-MB-231 and MDA-MB-468 cells. Ruyiping was also revealed to trigger cell cycle arrest at the G2 phase in MDA-MB-231 and MDA-MB-468 cells. Moreover, Ruyiping suppressed the migration and invasion abilities of MDA-MB-231 and MDA-MB-468 cells in vitro. Furthermore, Ruyiping blocked the activity of MMP9 in MDA-MB-231 and MDA-MB-468 cells. Additionally, western blotting showed that Ruyiping attenuated epithelial-to-mesenchymal transition (EMT) of breast cancer through downregulation of N-cadherin, Vimentin, Snail1, and Snail2 and upregulation of E-cadherin. The authors observed that the components of Ruyiping Pseudobulbus Cremastra seu pleiones polysaccharide and curcumol showed significant suppression in the growth and invasion of breast cancer cell. Conclusions: The observations of this study suggest the antitumor properties of Ruyiping in cell growth and invasion of breast cancer, which are modulated by induction of cell cycle arrest and reduction of MMP9 and EMT.

Entities:  

Keywords:  EMT; Ruyiping; breast cancer; cell cycle

Mesh:

Substances:

Year:  2019        PMID: 30901274     DOI: 10.1089/cbr.2018.2703

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  4 in total

Review 1.  Polysaccharides with Antitumor Effect in Breast Cancer: A Systematic Review of Non-Clinical Studies.

Authors:  Claudia Rita Corso; Natalia Mulinari Turin de Oliveira; Leonardo Moura Cordeiro; Karien Sauruk da Silva; Suzany Hellen da Silva Soczek; Virgilio Frota Rossato; Elizabeth Soares Fernandes; Daniele Maria-Ferreira
Journal:  Nutrients       Date:  2021-06-10       Impact factor: 5.717

Review 2.  Recent Advances in Anti-Metastatic Approaches of Herbal Medicines in 5 Major Cancers: From Traditional Medicine to Modern Drug Discovery.

Authors:  Jinkyung Park; Dahee Jeong; Meeryoung Song; Bonglee Kim
Journal:  Antioxidants (Basel)       Date:  2021-03-27

3.  Ruyiping formula inhibits metastasis via the microRNA-134-SLUG axis in breast cancer.

Authors:  Ziwei Jiang; Lixia Pei; Ying Xie; Qun Ye; Xiaoqiang Liang; Yiyi Ye; Sheng Liu
Journal:  BMC Complement Med Ther       Date:  2021-07-05

4.  Curcumol enhances the anti-tumor effects of metformin via suppressing epithelial-mesenchymal transition in triple-negative breast cancer.

Authors:  Gangyue Wang; Yi Dong; Heng Liu
Journal:  Ann Transl Med       Date:  2020-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.